Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors

This study has been terminated.
(Sponsor decision - subjects rolled over to protocol 20101116)
Sponsor:
Information provided by (Responsible Party):
Amgen
ClinicalTrials.gov Identifier:
NCT00819169
First received: January 6, 2009
Last updated: October 1, 2012
Last verified: October 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2011
  Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)